Literature DB >> 21039951

High-frequency stimulation of deep brain structures in obsessive-compulsive disorder: the search for a valid circuit.

William I A Haynes1, Luc Mallet.   

Abstract

Obsessive-compulsive disorder (OCD) is a common, disabling, psychiatric disease combining intrusive thoughts (obsessions) and repetitive behaviours (compulsions). Although most patients respond well to conventional pharmacological and/or psychological therapy, 25-30%, often with extremely severe symptoms, fail to improve after treatment. High-frequency stimulation of deep brain structures (basal ganglia included), a surgical technique developed for movement disorders and otherwise known as deep brain stimulation (DBS), has been proposed as an alternative to ablative surgery for these intractable cases. Here, we review the scientific data that explain why the use of this technique is currently being investigated in OCD, from the first hypotheses based on neuroimaging studies (anatomical and functional) to more recent animal models and clinical observations. The general outcome of each clinical trial is outlined in order to discuss its relation to pathophysiology; however, more specific clinical information (side-effects, latencies, and other behavioural modifications) is not given. Finally, a description of the models of OCD that stem from these data and how they might be affected by DBS is provided.
© 2010 The Authors. European Journal of Neuroscience © 2010 Federation of European Neuroscience Societies and Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2010        PMID: 21039951     DOI: 10.1111/j.1460-9568.2010.07418.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  22 in total

1.  Deep-Brain Stimulation for Basal Ganglia Disorders.

Authors:  Thomas Wichmann; Mahlon R Delong
Journal:  Basal Ganglia       Date:  2011-07-01

Review 2.  Neurobiology of obsessive-compulsive disorder: insights into neural circuitry dysfunction through mouse genetics.

Authors:  Jonathan T Ting; Guoping Feng
Journal:  Curr Opin Neurobiol       Date:  2011-05-24       Impact factor: 6.627

3.  Assessment of a method to determine deep brain stimulation targets using deterministic tractography in a navigation system.

Authors:  Josué M Avecillas-Chasin; Fernando Alonso-Frech; Olga Parras; Nayade Del Prado; Juan A Barcia
Journal:  Neurosurg Rev       Date:  2015-05-12       Impact factor: 3.042

Review 4.  Pediatric indications for deep brain stimulation.

Authors:  Matthew F DiFrancesco; Casey H Halpern; Howard H Hurtig; Gordon H Baltuch; Gregory G Heuer
Journal:  Childs Nerv Syst       Date:  2012-07-25       Impact factor: 1.475

Review 5.  Deep brain stimulation.

Authors:  X L Chen; Y Y Xiong; G L Xu; X F Liu
Journal:  Interv Neurol       Date:  2013-09

6.  Invasive and Non-invasive Neurostimulation for OCD.

Authors:  Isidoor O Bergfeld; Eva Dijkstra; Ilse Graat; Pelle de Koning; Bastijn J G van den Boom; Tara Arbab; Nienke Vulink; Damiaan Denys; Ingo Willuhn; Roel J T Mocking
Journal:  Curr Top Behav Neurosci       Date:  2021

Review 7.  Deep brain stimulation for psychiatric diseases: what are the risks?

Authors:  Christian Saleh; Denys Fontaine
Journal:  Curr Psychiatry Rep       Date:  2015-05       Impact factor: 5.285

Review 8.  Striatal circuits, habits, and implications for obsessive-compulsive disorder.

Authors:  Eric Burguière; Patricia Monteiro; Luc Mallet; Guoping Feng; Ann M Graybiel
Journal:  Curr Opin Neurobiol       Date:  2014-09-19       Impact factor: 6.627

9.  Optimizing a rodent model of Parkinson's disease for exploring the effects and mechanisms of deep brain stimulation.

Authors:  Karl Nowak; Eilhard Mix; Jan Gimsa; Ulf Strauss; Kiran Kumar Sriperumbudur; Reiner Benecke; Ulrike Gimsa
Journal:  Parkinsons Dis       Date:  2011-04-05

10.  Different patterns of local field potentials from limbic DBS targets in patients with major depressive and obsessive compulsive disorder.

Authors:  W-J Neumann; J Huebl; C Brücke; L Gabriëls; M Bajbouj; A Merkl; G-H Schneider; B Nuttin; P Brown; A A Kühn
Journal:  Mol Psychiatry       Date:  2014-02-11       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.